Back to Search Start Over

Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction

Authors :
Ribeiro, Gabriel H.
Guedes, Adriana P. M.
de Oliveira, Tamires D.
de Correia, Camila R. S. T. b.
Colina-Vegas, Legna
Lima, Mauro A.
Nóbrega, Joaquim A.
Cominetti, Márcia R.
Rocha, Fillipe V.
Ferreira, Antônio G.
Castellano, Eduardo E.
Teixeira, Felipe R.
Batista, Alzir A.
Source :
Inorganic Chemistry; October 2020, Vol. 59 Issue: 20 p15004-15018, 15p
Publication Year :
2020

Abstract

In this paper, a series of new ruthenium complexes of the general formula [Ru(NS)(dpphpy)(dppb)]PF6(Ru1–Ru3), where dpphpy = diphenyl-2-pyridylphosphine, NS ligands = 2-thiazoline-2-thiol (tzdt, Ru1), 2-mercaptopyrimidine (pySm, Ru2), and 4,6-diamino-2-mercaptopyrimidine (damp, Ru3), and dppb = 1,4-bis(diphenylphosphino)butane, were synthesized and characterized by elemental analysis, spectroscopic techniques (IR, UV/visible, and 1D and 2D NMR), and X-ray diffraction. In the characterization, the correlation between the phosphorus atoms and their respective aromatic hydrogen atoms of the compounds in the assignment stands outs, by 1H–31P HMBC experiments. The compounds show anticancer activities against A549 (lung) and MDA-MB-231 (breast) cancer cell lines, higher than the clinical drug cisplatin. All of the complexes are more cytotoxic against the cancer cell lines than against the MRC-5 (lung) and MCF-10A (breast) nontumorigenic human cell lines. For A549 tumor cells, cell cycle analysis upon treatment with Ru2showed that it inhibits the mitotic phase because arrest was observed in the Sub-G1 phase. Additionally, the compound induces cell death by an apoptotic pathway in a dose-dependent manner, according to annexin V-PE assay. The multitargeted character of the compounds was investigated, and the biomolecules were DNA, topoisomerase IB, and proteasome, as well as the fundamental biomolecule in the pharmacokinetics of drugs, human serum albumin. The experimental results indicate that the complexes do not target DNA in the cells. At low concentrations, the compounds showed the ability to partially inhibit the catalytic activity of topoisomerase IB in the process of relaxation of the DNA plasmid. Among the complexes assayed in cultured cells, complex Ru3was able to diminish the proteasomal chymotrypsin-like activity to a greater extent.

Details

Language :
English
ISSN :
00201669 and 1520510X
Volume :
59
Issue :
20
Database :
Supplemental Index
Journal :
Inorganic Chemistry
Publication Type :
Periodical
Accession number :
ejs54306847
Full Text :
https://doi.org/10.1021/acs.inorgchem.0c01835